Vasopressor titration regimen in the balanced multimodal group. by Žiga Kalamar (22145810)

Subjects:

The schedule of enrollment, interventions and assessments. by Žiga Kalamar (22145810)

Subjects:

The results of linear mixed model. by Soheila Qanbari (20455173)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects:

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

“…Any within or between contraceptive group androgenic effects on behavior in the brain are likely dominated by the androgenic activities of MPA and NET and not by the decreased endogenous testosterone levels. The clinical trial was registered with the Pan African Clinical Trials Registry (PACTR 202009758229976)</p>…”

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…AGs have played a significant role in clinical practice in recent years.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…AGs have played a significant role in clinical practice in recent years.…”

Scatterplot of observed barrier scores against knowledge scores (top) and confidence scores (bottom) with linear line of best fit. by Lisa Thiele (6468056)

Subjects:

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Effects of s-ketamine and midazolam on respiratory parameters. by Oscar F. C. van den Bosch (22184246)

Subjects:

Flow chart of the study participants. by Oscar F. C. van den Bosch (22184246)

Subjects:

Analysis of basic clinical data of the study population (± s). by Hao Deng (409186)

Subjects:

Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

Subjects:

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Main baseline characteristics of patients included in the study. by Jie Liu (15128)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…(B) Long-term-treatment with a low dose of netoglitazone also exhibits a patchy effect in decreasing plaque count. This effect is mainly observed in the olfactory, hindbrain, and visual areas. …”